Torax Medical recently updated the first round of the $ 25 million Series E announced in an SEC filing in late July, saying the round was led by Johnson & Johnson Innovation. Tour funds are intended to commercially develop its platform of products used to treat chronic diseases related to weak sphincter muscles, including its […]